Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Chan

Showing results (181-190 of 407) with videos related to

Pageof 41
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 4, 2010
Clinical predictors of response to cetuximab-chemotherapy in metastatic colorectal cancerAda T W Ma, Brigette B Y Ma, Kenny I K Lei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell linesTracey A Haigh, Xiaorong Lin, Hui Jia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinomaStephen L Chan, Frankie K F Mo, Vincent W S Wong, et al.
Annals of Emergency Medicine|May 8, 2009
The prevalence and factors associated with QTc prolongation among emergency department patientsMichael W Seftchick, Peter H Adler, Margaret Hsieh, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2010
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong KongE P Hui, L K S Leung, F Mo, et al.
Cancer Treatment Reviews|March 1, 2022
Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancersKenneth C W Wong, David Johnson, Edwin P Hui, et al.
The Anatomical Record|December 1, 1995
Ultrastructure and cytochemical staining characteristics of canine natural killer cellsD W Knapp, J J Turek, D B DeNicola, et al.
Scientific Reports|May 24, 2018
Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinomaChi-Hang Wong, Brigette B Y Ma, Connie W C Hui, et al.
Nature Reviews. Clinical Oncology|October 8, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccinesW K Jacky Lam, Brigette B Y Ma, Ann D King, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 20, 2020
Recent Advances in the Development of Biomarkers and Chemoradiotherapeutic Approaches for Nasopharyngeal CarcinomaBrigette B Y Ma, Yu-Pei Chen, Edwin P Hui, et al.
Pageof 41

Showing results (181-190 of 407) with videos related to

Sort By:
Pageof 41
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 4, 2010
Clinical predictors of response to cetuximab-chemotherapy in metastatic colorectal cancerAda T W Ma, Brigette B Y Ma, Kenny I K Lei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell linesTracey A Haigh, Xiaorong Lin, Hui Jia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinomaStephen L Chan, Frankie K F Mo, Vincent W S Wong, et al.
Annals of Emergency Medicine|May 8, 2009
The prevalence and factors associated with QTc prolongation among emergency department patientsMichael W Seftchick, Peter H Adler, Margaret Hsieh, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2010
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong KongE P Hui, L K S Leung, F Mo, et al.
Cancer Treatment Reviews|March 1, 2022
Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancersKenneth C W Wong, David Johnson, Edwin P Hui, et al.
The Anatomical Record|December 1, 1995
Ultrastructure and cytochemical staining characteristics of canine natural killer cellsD W Knapp, J J Turek, D B DeNicola, et al.
Scientific Reports|May 24, 2018
Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinomaChi-Hang Wong, Brigette B Y Ma, Connie W C Hui, et al.
Nature Reviews. Clinical Oncology|October 8, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccinesW K Jacky Lam, Brigette B Y Ma, Ann D King, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 20, 2020
Recent Advances in the Development of Biomarkers and Chemoradiotherapeutic Approaches for Nasopharyngeal CarcinomaBrigette B Y Ma, Yu-Pei Chen, Edwin P Hui, et al.
Pageof 41